ZyCoV-D, the world’s first and India’s indigenously developed DNA based vaccine against Covid-19. Zydus Cadila plans to make 100 to 120 million doses of Zycov-D annually.
ZyCoV-D will be administered in children above 12 years and adults. The company also plans to seek approval for the two-dose regimen of the vaccine. Here's your 10-point cheatsheet to this big story: 1. “Developed in partnership with the Department of Biotechnology, Government of India under the ‘Mission COVID Suraksha’ and implemented by BIRAC, ZyCoV-D has been supported under COVID-19 Research Consortia through National Biopharma Mission for Preclinical studies, Phase I and Phase II Clinical Trials and under the Mission COVID Suraksha for Phase III Clinical Trial,"